MedTrace Logo

Cyanophyta Aphanizomenon Flos-aquae, and Adipose Stroma Vascular Fraction, in Heart Failure Patient

NCT04515537 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2023-01-03

No results posted yet for this study

Summary

This study is a prospective, randomized, controlled trial to assess the efficacy of transplantation of autologous stroma vauscultar fraction and/or AFA in 15 patients with ischemic heart failure

Conditions

  • Congestive Heart Failure Chronic

Interventions

DIETARY_SUPPLEMENT

Water-soluble Extract of the Cyanophyta Aphanizomenon Flos-aquae (AFA),

Patient use 2 capsules 3 time a day by oral.

PROCEDURE

Infiltrtion of SVf

After filling up the informed consent Mini liposuction is performed under local anesthesia with klein solution, about 70 cc of dry fat tissue is suctioned and collagenase digestion is done with final centrifugation to obtain the SVF

Sponsors & Collaborators

  • Clinica Castello 68

    collaborator OTHER

  • Sociedad Española de Medicina Regenerativa y Terapia Celular

    lead OTHER

Principal Investigators

  • Miguel G Garber, MD · Healthy Longevity Clinic

  • Christian Drapeau, PhD · Kalyagen

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-20
Primary Completion
2022-12-15
Completion
2023-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04515537 on ClinicalTrials.gov